BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4042115)

  • 1. The beneficial effect of amrinone on acute drug-induced heart failure in the anaesthetised dog.
    Alousi AA; Canter JM; Fort DJ
    Cardiovasc Res; 1985 Aug; 19(8):483-94. PubMed ID: 4042115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-related cardiovascular effects of amrinone during enflurane anesthesia in the dog.
    Makela VH; Kapur PA
    Anesth Analg; 1986 Aug; 65(8):849-52. PubMed ID: 3729021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amrinone in the management of low cardiac output after open heart surgery.
    Goenen M; Pedemonte O; Baele P; Col J
    Am J Cardiol; 1985 Jul; 56(3):33B-38B. PubMed ID: 4025158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative immediate hemodynamic and hormonal effects of amrinone and captopril in patients with severe chronic heart failure.
    Packer M; Medina N; Yushak M
    Am J Med Sci; 1986 Jan; 291(1):8-15. PubMed ID: 3510545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure.
    Konstam MA; Cohen SR; Weiland DS; Martin TT; Das D; Isner JM; Salem DN
    Am J Cardiol; 1986 Feb; 57(4):242-8. PubMed ID: 3004184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amrinone and verapamil-propranolol induced cardiac depression during isoflurane anesthesia in dogs.
    Makela VH; Kapur PA
    Anesthesiology; 1987 Jun; 66(6):792-7. PubMed ID: 3592277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced relaxation and reduced positive inotropic effects of amrinone in ventricular muscle from cats with subacute heart failure. Implications for drug therapy.
    Bassett AL; Gaide MS; Lodge NJ; Cameron JS
    Adv Myocardiol; 1985; 6():629-36. PubMed ID: 2986264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous amrinone in left ventricular failure complicated by acute myocardial infarction.
    Taylor SH; Verma SP; Hussain M; Reynolds G; Jackson NC; Hafizullah M; Richmond A; Silke B
    Am J Cardiol; 1985 Jul; 56(3):29B-32B. PubMed ID: 4025156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiotonic activity of amrinone--Win 40680 [5-amino-3,4'-bipyridine-6(1H)-one].
    Alousi AA; Farah AE; Lesher GY; Opalka CJ
    Circ Res; 1979 Nov; 45(5):666-77. PubMed ID: 39684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular pharmacology of 6-[4-(4'-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride, a novel and potent cardiotonic agent with vasodilator properties.
    Narimatsu A; Kitada Y; Satoh N; Suzuki R; Okushima H
    Arzneimittelforschung; 1987 Apr; 37(4):398-406. PubMed ID: 3606694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intracoronary and intravenous amrinone infusions in patients with cardiac failure and patients with near normal cardiac function.
    Wilmshurst PT; Thompson DS; Juul SM; Dittrich HC; Dawson JR; Walker JM; Jenkins BS; Coltart DJ; Webb-Peploe MM
    Br Heart J; 1985 May; 53(5):493-506. PubMed ID: 3994862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive inotropic and hemodynamic properties of flosequinan, a new vasodilator, and a sulfone metabolite.
    Falotico R; Haertlein BJ; Lakas-Weiss CS; Salata JJ; Tobia AJ
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):412-8. PubMed ID: 2476620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous use of amrinone for the treatment of the failing heart.
    Mancini D; LeJemtel T; Sonnenblick E
    Am J Cardiol; 1985 Jul; 56(3):8B-15B. PubMed ID: 2411122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative vasoactive therapy for heart failure.
    Benotti JR; McCue JE; Alpert JS
    Am J Cardiol; 1985 Jul; 56(3):19B-24B. PubMed ID: 4025154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of the bipyridines: amrinone and milrinone.
    Alousi AA; Johnson DC
    Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of intravenous amrinone: the first of a new class of positive inotropic agents with vasodilator properties.
    Bottorff MB; Rutledge DR; Pieper JA
    Pharmacotherapy; 1985; 5(5):227-37. PubMed ID: 3906583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of cardiac failure.
    Weber KT; Janicki JS; Maskin CS
    Am J Cardiol; 1985 Jul; 56(3):3B-7B. PubMed ID: 4025157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dose-dependent effect of amrinone on hemodynamics, myocardial circulation and myocardial energy requirement. An experimental study].
    Veit S; Brückner JB; Vogt K; Wagner R; Hess W
    Z Kardiol; 1985 Feb; 74(2):76-84. PubMed ID: 3993153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The cardiovascular effect of Cordemcura on various animal models in vivo].
    Rohde E; Muschick P; Modersohn D; Landmann H; Löwe H
    Pharmazie; 1986 Mar; 41(3):194-5. PubMed ID: 3714794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New positive inotropic drugs for the treatment of congestive heart failure.
    Sonnenblick EH; Mancini DM; LeJemtel TH
    Am J Cardiol; 1985 Jan; 55(2):41A-44A. PubMed ID: 2981465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.